NASDAQ:BCEL - Atreca News Headlines

$21.87
-0.17 (-0.77 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$21.20
Now: $21.87
$23.54
50-Day Range
$10.61
MA: $15.24
$22.20
52-Week Range
$10.29
Now: $21.87
$23.65
Volume190,942 shs
Average Volume84,248 shs
Market Capitalization$585.68 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Atreca (NASDAQ BCEL) News Headlines

Source:
DateHeadline
Atrecas (BCEL) Buy Rating Reiterated at Brookline Capital ManagementAtreca's (BCEL) Buy Rating Reiterated at Brookline Capital Management
www.americanbankingnews.com - August 24 at 8:25 AM
 Brokerages Expect Atreca (NASDAQ:BCEL) to Announce -$0.55 EPS Brokerages Expect Atreca (NASDAQ:BCEL) to Announce -$0.55 EPS
www.americanbankingnews.com - August 16 at 6:26 AM
Atreca (NASDAQ:BCEL) Announces  Earnings ResultsAtreca (NASDAQ:BCEL) Announces Earnings Results
www.americanbankingnews.com - August 14 at 10:21 AM
Atreca (NASDAQ:BCEL) Given Buy Rating at CowenAtreca (NASDAQ:BCEL) Given Buy Rating at Cowen
www.americanbankingnews.com - August 14 at 7:11 AM
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate DevelopmentsAtreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
finance.yahoo.com - August 13 at 8:19 PM
 Atreca (NASDAQ:BCEL) Given $25.50 Average Price Target by Analysts Atreca (NASDAQ:BCEL) Given $25.50 Average Price Target by Analysts
www.americanbankingnews.com - August 9 at 8:46 PM
 Atreca (NASDAQ:BCEL) Receives Consensus Recommendation of "Strong Buy" from Brokerages Atreca (NASDAQ:BCEL) Receives Consensus Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - August 9 at 8:46 PM
Stifel: Atreca Offers Attractive Oncology Drug Development PlayStifel: Atreca Offers Attractive Oncology Drug Development Play
www.benzinga.com - July 15 at 3:15 PM
Wells sees 33% upside in Gilead in premarket analyst actionWells sees 33% upside in Gilead in premarket analyst action
seekingalpha.com - July 15 at 8:41 AM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel